Enzyme Replacement Therapy Market Share

Market Share of Enzyme Replacement Therapy Industry

Companies have been taking strategic initiatives related to enzyme replacement therapy to grow their presence in the market. For instance, recently Takeda exhibited its recent advances for lysosomal storage disorders at World Symposium in Orlando. Some of the key players who have been currently dominating the market are Genzyme Corporation, Pfizer Inc., Leadiant Biosciences, Inc., Biomarin Pharmaceutical Inc., Takeda Pharmaceutical Company Limited, Protalix Biotherapeutics, Amicus Therapeutics, and Johnson & Johnson Services Inc.

Enzyme Replacement Therapy Market Leaders

1. Genzyme Corporation

2. Pfizer Inc.

3. Leadiant Biosciences Inc.

4. Biomarin Pharmaceuticals Inc.

5. Takeda pharmaceutical Company Ltd.

*Disclaimer: Major Players sorted in no particular order